RESEARCH
The research in the Liu lab leverages cancer elements to develop new drugs for the treatment of neurological disorders and mental illnesses.
Our research program has led to four patented products, such as tumor suppressor microRNAs and FDA-approved kinase inhibitors to treat acute brain injury and mental illness.
RESEARCH TOPICS:
- Developing tumor suppressor miR-XXX for treatment of multiple brain injury
- Developing tumor suppressor miR-XXX for treatment of brain trauma and mental illness.
- Developing FDA-approved kinase inhibitor abemacilib and analogs for TBI therapy
- Developing FDA-approved kinase inhibitor dasatiniband analogs for TBI therapy
- Repurposing abemacilibfor treatment of TBI in humans (clinical trials)
- Repurposing dasatinib for treatment of TBI in humans (clinical trials)